Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire4 weeks ago
Dana and Allison Announce All Required Regulatory Approvals Received for Off-Highway Business Transaction
MAUMEE, Ohio and INDIANAPOLIS, Nov. 19, 2025 /PRNewswire/ — Dana Incorporated (NYSE: DAN) and Allison Transmission Holdings, Inc. (NYSE: ALSN)…
Read More » -
Cision PR Newswire4 weeks ago
Breakthrough Properties and Eli Lilly and Company Partner to Bring Lilly Gateway Labs to Newly-Developed 2300 Market Street in Philadelphia
“Lilly Gateway Labs at Breakthrough” in Center City Will Offer Cutting-Edge Biotechnology Companies Science-Ready Suites Featuring Staffing, Programming and Amenities…
Read More » -
Cision PR Newswire4 weeks ago
Lilly announces plans to open Lilly Gateway Labs site in Philadelphia
Gateway Labs model provides lab space and tailored scientific engagement to fuel next-generation medicines New Center City site, in partnership…
Read More » -
Cision PR Newswire4 weeks ago
The Rise of Advanced Maternal Age IVF: BaseCare Medical’-B(2170.HK) AI “Undisturbed Culture” Empowers Intelligent Assisted Reproduction
SUZHOU, China, Nov. 19, 2025 /PRNewswire/ — Data from the keynote report at the 18th Annual Conference of the Chinese…
Read More » -
Business Wire4 weeks ago
Ryder & BJC Health System Secure SMI Collaboration Award for Transforming Healthcare Supply Chain, Enhancing Patient Care
Strategic Collaboration Delivers Near 100% Fulfillment Rates, 100% Real-Time Visibility, and Resilient Medical Logistics Across 14 Hospitals MIAMI–(BUSINESS WIRE)–#Collaboration—Ryder System,…
Read More » -
Business Wire4 weeks ago
Bullish Reports Third Quarter 2025 Results
Bullish posts record Adjusted Revenue, Adjusted EBITDA, and Adjusted Net Income for Q3’2025 Bullish beats guided ranges on Subscription, Services,…
Read More » -
Business Wire4 weeks ago
Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) in Treatment-Naïve Adults with HIV-1 Infection
Investigational DOR/ISL is the first non-INSTI, two-drug regimen to demonstrate non-inferiority to BIC/FTC/TAF in a Phase 3 clinical trial in…
Read More » -
Business Wire4 weeks ago
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. Announces Preliminary Results of Rights Offering
WEST PALM BEACH, Fla.–(BUSINESS WIRE)–RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (the “Fund”) (NYSE: OPP) today announced the preliminary results of its…
Read More » -
Cision PR Newswire4 weeks ago
VIAVI Receives Award from U.S. Department of Transportation to Advance Complementary Position, Navigation, and Timing (CPNT) for Critical Infrastructure
VIAVI assured PNT solutions will be integrated at NTIA-funded VALOR™ and ORCID Labs to test and demonstrate their ability to…
Read More » -
Cision PR Newswire4 weeks ago
Kennametal to Attend Goldman Sachs Industrials and Materials Conference
PITTSBURGH, Nov. 19, 2025 /PRNewswire/ — Kennametal Inc. (NYSE: KMT) announced today that they will attend the Goldman Sachs Industrials…
Read More »




